+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Alzheimer's Disease - Pipeline Review, H1 2020

  • ID: 4997661
  • Drug Pipelines
  • February 2020
  • Region: Global
  • 1716 pages
  • Global Markets Direct
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • 1st Bio Therapeutics Inc
  • Astellas Pharma Inc
  • Dong Wha Pharma Co Ltd
  • Invisio Ltd
  • NeuroSolis Inc
  • Samus Therapeutics LLC
  • MORE
Alzheimer's Disease - Pipeline Review, H1 2020

Summary

This latest Pharmaceutical and Healthcare disease pipeline guide Alzheimer's Disease - Pipeline Review, H1 2020, provides an overview of the Alzheimer's Disease (Central Nervous System) pipeline landscape.

Alzheimer's disease is a progressive, degenerative condition causing damage to the memory and behavior due to the attack on the neurons. These neurons are responsible for the synthesis of neurotransmitter acetylcholine which is further responsible for the transmission of signals. Predisposing factors include age, heredity, cardiovascular diseases or diabetes and environmental factors. Symptoms include depression, anxiety, social withdrawal, irritability and aggressiveness.

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide Alzheimer's Disease - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Alzheimer's Disease (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Alzheimer's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alzheimer's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 20, 64, 74, 4, 320, 129 and 9 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 2, 3, 100 and 45 molecules, respectively.

Alzheimer's Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Alzheimer's Disease (Central Nervous System).
  • The pipeline guide reviews pipeline therapeutics for Alzheimer's Disease (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Alzheimer's Disease (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Alzheimer's Disease (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Alzheimer's Disease (Central Nervous System)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Alzheimer's Disease (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Alzheimer's Disease (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 1st Bio Therapeutics Inc
  • Astellas Pharma Inc
  • Dong Wha Pharma Co Ltd
  • Invisio Ltd
  • NeuroSolis Inc
  • Samus Therapeutics LLC
  • MORE
Introduction
Alzheimer's Disease - Overview
Alzheimer's Disease - Therapeutics Development
Alzheimer's Disease - Therapeutics Assessment
Alzheimer's Disease - Companies Involved in Therapeutics Development
Alzheimer's Disease - Drug Profiles
Alzheimer's Disease - Dormant Projects
Alzheimer's Disease - Discontinued Products
Alzheimer's Disease - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Alzheimer's Disease, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..3), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..4), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..5), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..6), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..7), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..8), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..9), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..10), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..11), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..12), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..13), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..14), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..15), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..16), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..17), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..18), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..19), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..20), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020 (Contd..2), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020 (Contd..3), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020 (Contd..4), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020 (Contd..5), H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Companies, H1 2020 (Contd..3), H1 2020
Products under Development by Companies, H1 2020 (Contd..4), H1 2020
Products under Development by Companies, H1 2020 (Contd..5), H1 2020
Products under Development by Companies, H1 2020 (Contd..6), H1 2020
Products under Development by Companies, H1 2020 (Contd..7), H1 2020
Products under Development by Companies, H1 2020 (Contd..8), H1 2020
Products under Development by Companies, H1 2020 (Contd..9), H1 2020
Products under Development by Companies, H1 2020 (Contd..10), H1 2020
Products under Development by Companies, H1 2020 (Contd..11), H1 2020
Products under Development by Companies, H1 2020 (Contd..12), H1 2020
Products under Development by Companies, H1 2020 (Contd..13), H1 2020
Products under Development by Companies, H1 2020 (Contd..14), H1 2020
Products under Development by Companies, H1 2020 (Contd..15), H1 2020
Products under Development by Companies, H1 2020 (Contd..16), H1 2020
Products under Development by Companies, H1 2020 (Contd..17), H1 2020
Products under Development by Companies, H1 2020 (Contd..18), H1 2020
Products under Development by Companies, H1 2020 (Contd..19), H1 2020
Products under Development by Companies, H1 2020 (Contd..20), H1 2020
Products under Development by Companies, H1 2020 (Contd..21), H1 2020
Products under Development by Companies, H1 2020 (Contd..22), H1 2020
Products under Development by Companies, H1 2020 (Contd..23), H1 2020
Products under Development by Companies, H1 2020 (Contd..24), H1 2020
Products under Development by Companies, H1 2020 (Contd..25), H1 2020
Products under Development by Companies, H1 2020 (Contd..26), H1 2020
Products under Development by Companies, H1 2020 (Contd..27), H1 2020
Products under Development by Companies, H1 2020 (Contd..28), H1 2020
Products under Development by Companies, H1 2020 (Contd..29), H1 2020
Products under Development by Companies, H1 2020 (Contd..30), H1 2020
Products under Development by Companies, H1 2020 (Contd..31), H1 2020
Products under Development by Companies, H1 2020 (Contd..32), H1 2020
Products under Development by Universities/Institutes, H1 2020
Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020
Products under Development by Universities/Institutes, H1 2020 (Contd..2), H1 2020
Products under Development by Universities/Institutes, H1 2020 (Contd..3), H1 2020
Products under Development by Universities/Institutes, H1 2020 (Contd..4), H1 2020
Products under Development by Universities/Institutes, H1 2020 (Contd..5), H1 2020
Products under Development by Universities/Institutes, H1 2020 (Contd..6), H1 2020
Products under Development by Universities/Institutes, H1 2020 (Contd..7), H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..2), H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..3), H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..4), H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..5), H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..6), H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..7), H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..8), H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..9), H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..10), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..2), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..3), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..4), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..5), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..6), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..7), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..8), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..9), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..10), H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Alzheimer's Disease - Pipeline by 1st Bio Therapeutics Inc, H1 2020
Alzheimer's Disease - Pipeline by 2A Pharma AB, H1 2020
Alzheimer's Disease - Pipeline by 4D Pharma Plc, H1 2020
Alzheimer's Disease - Pipeline by 4P-Pharma SAS, H1 2020
Alzheimer's Disease - Pipeline by AB Science SA, H1 2020
Alzheimer's Disease - Pipeline by Abaxy Sprl, H1 2020
Alzheimer's Disease - Pipeline by AbbVie Inc, H1 2020
Alzheimer's Disease - Pipeline by AC Immune SA, H1 2020
Alzheimer's Disease - Pipeline by Acelerox LLC, H1 2020
Alzheimer's Disease - Pipeline by Acelot Inc, H1 2020
Alzheimer's Disease - Pipeline by Actinogen Medical Ltd, H1 2020
Alzheimer's Disease - Pipeline by Acumen Pharmaceuticals Inc, H1 2020
Alzheimer's Disease - Pipeline by AcuraStem Inc, H1 2020
Alzheimer's Disease - Pipeline by Addex Therapeutics Ltd, H1 2020
Alzheimer's Disease - Pipeline by Adocia SAS, H1 2020
Alzheimer's Disease - Pipeline by ADRx Inc, H1 2020
Alzheimer's Disease - Pipeline by Aerobyx LLC, H1 2020
Alzheimer's Disease - Pipeline by AfaSci Inc, H1 2020
Alzheimer's Disease - Pipeline by Affichem SA, H1 2020
Alzheimer's Disease - Pipeline by AFFiRiS AG, H1 2020
Alzheimer's Disease - Pipeline by Aibios Co Ltd, H1 2020
Alzheimer's Disease - Pipeline by Alector Inc, H1 2020

List of Figures
Number of Products under Development for Alzheimer's Disease, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 1st Bio Therapeutics Inc
  • 2A Pharma AB
  • 4D Pharma Plc
  • 4P-Pharma SAS
  • AB Science SA
  • Abaxy Sprl
  • AbbVie Inc
  • AC Immune SA
  • Acelerox LLC
  • Acelot Inc
  • Actinogen Medical Ltd
  • Acumen Pharmaceuticals Inc
  • AcuraStem Inc
  • Addex Therapeutics Ltd
  • Adocia SAS
  • ADRx Inc
  • Aerobyx LLC
  • AfaSci Inc
  • Affichem SA
  • AFFiRiS AG
  • Aibios Co Ltd
  • Alector Inc
  • AlfaSigma SpA
  • Alion Pharmaceuticals Inc
  • Alkahest Inc
  • Alkermes Plc
  • ALS Biopharma LLC
  • Alsonex Pty Ltd
  • ALSP Inc
  • Alzamend Neuro Inc
  • AlzeCure Pharma AB
  • Alzheon Inc
  • Alzhyme Pty Ltd
  • Alzinova AB
  • AlzProtect SAS
  • Alzyn LLC
  • Amarantus Bioscience Holdings Inc
  • Amylon LLC
  • Amylyx Pharmaceutical Corp
  • Anavex Life Sciences Corp
  • Ankar Pharma SL
  • Annovis Bio Inc
  • Antoxerene Inc
  • Anven AlzDx Inc
  • Aphios Corp
  • Apodemus AB
  • Apollo Therapeutics LLC
  • Applied Research using OMIC Sciences SL
  • Aprinoia Therapeutics Inc
  • AptaBio Therapeutics Inc
  • Araclon Biotech SL
  • Archer Pharmaceuticals Inc
  • AriBio
  • ArmaGen Inc
  • Armgo Pharma Inc
  • Artery Therapeutics Inc
  • Arvinas Inc
  • Asceneuron SA
  • Asdera LLC
  • AskAt Inc
  • Asklepios BioPharmaceutical Inc
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Astrocyte Pharmaceuticals Inc
  • Athira Pharma Inc
  • ATP Biopharm
  • Augustus BioTarget Inc
  • Auransa Inc
  • Aurin Biotech Inc
  • Auritec Pharmaceuticals Inc
  • Autifony Therapeutics Ltd
  • Autophagy Neurotherapeutics Inc
  • Avanti Biosciences Inc
  • Avidin Ltd
  • Avineuro Pharmaceuticals Inc
  • Axon Neuroscience SE
  • Axxam SpA
  • AZTherapies Inc
  • BCWorld Pharm Co Ltd
  • Beactica AB
  • Berg LLC
  • BeyondBio Inc
  • Bio-Pharm Solutions Co Ltd
  • BioArctic AB
  • Biogen Inc
  • Biohaven Pharmaceutical Holding Company Ltd
  • Biorchestra Ltd
  • BioXcel Therapeutics Inc
  • Boehringer Ingelheim International GmbH
  • Bolder Biotechnology Inc
  • Boryung Pharmaceutical Co Ltd
  • Brainvectis SAS
  • Bristol-Myers Squibb Co
  • BSIM Therapeutics SA
  • Cantabio Pharmaceuticals Inc
  • Capo Therapeutics Inc
  • Carna Biosciences Inc
  • Cassava Sciences Inc
  • CavoGene LifeSciences
  • CellCure
  • Celon Pharma SA
  • Cenna Biosciences Inc
  • Cennerv Pharma (S) Pte Ltd
  • Center Laboratories Inc
  • CerebraMed
  • Cerebrum Therapeutics Inc
  • Cerecin Inc
  • Cesa Alliance SA
  • CHA Bio & Diostech Co Ltd
  • Changchun Huayang High-Tech Co Ltd
  • Chaperone Therapeutics Inc
  • Chong Kun Dang Pharmaceutical Corp
  • Clayton Biotechnologies Inc
  • Clera Inc
  • CMG Pharmaceutical Co Ltd
  • Cogentis Therapeutics Inc
  • Cognition Therapeutics Inc
  • Cognosci Inc
  • CohBar Inc
  • Collaborations Pharmaceuticals Inc
  • Collaborative Medicinal Development LLC
  • CoPlex Therapeutics LLC
  • Corium, Inc.
  • Cortexyme Inc
  • Cortice Biosciences Inc
  • Cotinga Pharmaceuticals Inc
  • Covalent Bioscience Inc
  • Crossbeta Biosciences BV
  • CuroNZ Ltd
  • Cyclerion Therapeutics Inc
  • Cyclo Therapeutics Inc
  • Daewoong Pharmaceutical Co Ltd
  • DanPET AB
  • DegenRx BV
  • Denali Therapeutics Inc
  • Denovo Biopharma LLC
  • Diffusion Pharmaceuticals Inc
  • Dong Wha Pharma Co Ltd
  • Dong-A ST Co Ltd
  • DongKoo Bio & Pharma Co Ltd
  • Dongkook Pharmaceutical Co Ltd
  • E-scape Bio Inc
  • EastGate Pharmaceuticals Inc
  • Eikonizo Therapeutics Inc
  • EIP Pharma LLC
  • Eisai Co Ltd
  • Eleusis Ltd
  • Elevian Inc
  • Eli Lilly and Co
  • Elixirgen Therapeutics LLC
  • Emerald Organic Products Inc
  • EmphyCorp Inc
  • Endece LLC
  • Enterin Inc
  • Epigen Biosciences Inc
  • Epitracker Inc
  • Everfront Biotech Inc
  • F. Hoffmann-La Roche Ltd
  • Fortuna Fix Inc
  • Fujifilm Toyama Chemical Co Ltd
  • GABA Therapeutics Inc
  • Gabaeron Inc
  • Galimedix Therapeutics Ltd
  • GemVax & KAEL Co Ltd
  • Genentech Inc
  • Genervon Biopharmaceuticals LLC
  • GeneScience Pharmaceuticals Co Ltd
  • Genuv Inc
  • Gismo Therapeutics Inc
  • GlaxoSmithKline Plc
  • GliaCure Inc
  • Glialogix Inc
  • Glycadia Inc
  • GMP BIO Co Ltd
  • GNT Pharma Co Ltd
  • Golden Biotechnology Corp
  • Grespo AB
  • Grifols SA
  • Guangzhou-Sheng Jian Chi Pharmaceutical Co Ltd
  • GYRUS Pharmaceuticals Inc
  • H. Lundbeck AS
  • Halo Mountain LLC
  • Hana Pharm Co Ltd
  • HEC Pharm Co Ltd
  • HitGen LTD
  • Hope Biosciences LLC
  • HSRx Group
  • Hyundai Pharmaceutical Co Ltd
  • ICB International Inc
  • Icure Pharmaceutical Inc
  • IFM Therapeutics LLC
  • Imago Pharmaceuticals Inc
  • Immungenetics AG
  • ImmunoBrain Checkpoint Inc
  • ImmunoChem Therapeutics LLC
  • Immunwork Inc
  • ImStar Therapeutics Inc
  • Inflazome Ltd
  • Inmune Bio Inc
  • InnoBioscience LLC
  • Innosense LLC
  • Innovimmune Biotherapeutics Inc
  • Instituto Biomar SA
  • Insys Therapeutics Inc
  • IntelGenx Corp
  • Intra-Cellular Therapies Inc
  • IntraBio Ltd
  • Invisio Ltd
  • Io Therapeutics Inc
  • Ionis Pharmaceuticals Inc
  • Jace Biomedical Inc
  • Jiangsu Kangyuan Pharmaceutical Co Ltd
  • Jiangsu Kanion Pharmaceutical Co Ltd
  • Johnson & Johnson
  • Jupiter Orphan Therapeutics Inc
  • K-Stemcell Co Ltd
  • Kalgene Pharmaceuticals Inc
  • Karuna Therapeutics Inc
  • Keypharma Biomedical Inc
  • Keystone Bio Inc
  • Kine Sciences
  • KinoPharma Inc
  • Klogene Therapeutics Inc
  • Kogenix Therapeutics Inc
  • Kordate Solutions Inc
  • Kyowa Kirin Co Ltd
  • LA Cell Inc
  • Lauren Sciences LLC
  • Lead Discovery Center GmbH
  • Les Laboratoires Servier SAS
  • Libella Gene Therapeutics
  • Lipopharma Therapeutics SL
  • Longeveron LLC
  • Lyndra Inc
  • Madera BioSciences Inc
  • Magnolia Neurosciences Corp
  • ManRos Therapeutics
  • Med-Life Discoveries LP
  • MedaRed Inc
  • MedDay SA
  • Medesis Pharma SA
  • MEDRx Co Ltd
  • MeiraGTx Holdings Plc
  • Mercia Pharma Inc
  • Merck & Co Inc
  • Metabolic Solutions Development Company LLC
  • MetiMedi Pharmaceuticals Co Ltd
  • MetrioPharm AG
  • MetVital Inc
  • MGC Pharmaceuticals Ltd
  • MindImmune Therapeutics Inc
  • Mission Therapeutics Ltd
  • Mitoconix Bio Ltd
  • Modag GmbH
  • Montisera Ltd
  • NAL Pharmaceuticals Ltd
  • Nanjing Sanhome Pharmaceutical Co Ltd
  • Nanna Therapeutics Ltd
  • Nanomerics Ltd
  • NatureWise Biotech & Medicals Corp
  • NeoCytex Biopharma Inc
  • NeoNeuro SAS
  • Nerve Access Inc
  • NeuExcell Therapeutics Inc
  • Neuracle Science Co Ltd
  • Neuraly Inc
  • Neurim Pharmaceuticals Ltd
  • Neurimmune Holding AG
  • Neuro Bio Ltd
  • Neuro-Sys SAS
  • NeuroActiva Inc
  • Neurodegeneration Therapeutics Inc
  • Neurodon LLC
  • Neurodyn Life Sciences Inc
  • NeuroGeneration Inc
  • NeuroGenetic Pharmaceuticals Inc
  • Neurokine Therapeutics
  • NeuroLucent Inc
  • NeuroNascent Inc
  • NeurOp Inc
  • Neuropore Therapies Inc
  • NeuroScientific Biopharmaceuticals Ltd
  • NeuroSolis Inc
  • Neurotez Inc
  • NeuroTherpia Inc
  • Neurotrope Bioscience Inc
  • New World Laboratories Inc
  • NKMAX Co Ltd
  • NoNO Inc
  • Novartis AG
  • NovMetaPharma Co Ltd
  • Novoron Bioscience Inc
  • Oleolive LLC
  • Oligomerix inc
  • OncoSynergy Inc
  • Ono Pharmaceutical Co Ltd
  • Orphi Therapeutics Inc
  • Oryzon Genomics SA
  • OTR3 SAS
  • Ovensa Inc
  • Overseas Pharmaceuticals Ltd
  • Oxstem Ltd
  • P2D Inc
  • Panorama Research Inc
  • Park Active Molecules
  • Partner Therapeutics Inc
  • Peptron Inc
  • Pharmasum Therapeutics AS
  • PharmatrophiX Inc
  • Pharmazz Inc
  • Pharnext SA
  • Phenoquest AG
  • Phoenix Biotechnology Inc
  • Phoenix Life Sciences International Ltd
  • Plico Biotech Inc
  • Polaryx Therapeutics Inc
  • Prevacus Inc
  • Priavoid GmbH
  • Prilenia Therapeutics Development Ltd
  • Proclara Biosciences Inc
  • Progenra Inc
  • ProMIS Neurosciences Inc
  • Proteome Sciences Plc
  • Prothena Corp Plc
  • Protheragen Inc
  • Prous Institute for Biomedical Research SA
  • Provaidya LLC
  • Provention Bio Inc
  • PTC Therapeutics Inc
  • Quimatryx SL
  • Recombinant Technologies LLC
  • Regenacy Pharmaceuticals LLC
  • Regenera Pharma Ltd
  • reMYND NV
  • ReNetX Bio
  • Resilio Therapeutics LLC
  • Retrotope Inc
  • Revalesio Corp
  • Revivo Therapeutics Inc
  • Rodos BioTarget GmbH
  • Sage Therapeutics Inc
  • Samjin Pharm Co Ltd
  • Samumed LLC
  • Samus Therapeutics LLC
  • SanBio Inc
  • Sangamo Therapeutics Inc
  • Sanofi
  • SBI Pharmaceuticals Co Ltd
  • Scientus Pharma Inc
  • Selonterra Inc
  • Seneca Biopharma Inc
  • Sentinel Oncology Ltd
  • Serometrix LLC
  • SevenGenes Inc
  • Shanghai Angecon Biotechnology Corp
  • Shanghai Green Valley Pharmaceutical Co Ltd
  • Shanghai Rixin Biological Co Ltd
  • Shanghai SIMR Biotech Co Ltd
  • Shaperon Inc
  • Shionogi & Co Ltd
  • Simcere Pharmaceutical Group
  • Siragen Pharmaceuticals Inc
  • Smart Biomolecules Inc
  • Sosei Heptares
  • SparkBioPharma Inc
  • Spherium Biomed SL
  • Spinogenix Inc
  • Starwise Therapeutics LLC
  • Stream Biomedical Inc
  • Sunovion Pharmaceuticals Inc
  • Suven Life Sciences Ltd
  • SynapTEX LLC
  • T3D Therapeutics Inc
  • Taho Pharmaceuticals Ltd
  • Takeda Pharmaceutical Co Ltd
  • TauC3 Biologics Ltd
  • TauRx Therapeutics Ltd
  • Techfields Pharma Co Ltd
  • TechnoPhage SA
  • Teikoku Pharma USA Inc
  • Telocyte LLC
  • Tetra Therapeutics
  • Tetraneuron SL
  • Thera Neuropharma Inc
  • Tiantai Medical Technology Pty Ltd
  • Tonix Pharmaceuticals Holding Corp
  • Tranquis Therapeutics Inc
  • Treeway BV
  • Treventis Corp
  • Tria Bioscience Corp
  • UCB SA
  • United Neuroscience Ltd
  • Vaccinex Inc
  • Vanworld Pharmaceutical (Rugao) Company Ltd
  • Varinel Inc
  • Velacor Therapeutics Pty Ltd
  • VFP Therapies
  • Videns Incorp Ltd
  • Virobay Inc
  • Virogenics Inc
  • Vitruvian Biomedical Inc
  • Vivoryon Therapeutics AG
  • Vivreon Biosciences LLC
  • Voronoi
  • Voyager Therapeutics Inc
  • vTv Therapeutics Inc
  • Vybion Inc
  • Wayshine Biopharma Inc
  • Xcelthera INC
  • Xenexus Pharmaceuticals Pty Ltd
  • Xigen SA
  • Xonovo Inc
  • Yasham P2D Lifesciences Pvt Ltd
  • Yuma Therapeutics Corp
  • Yumanity Therapeutics
  • Zensun (Shanghai) Sci & Tech Co Ltd
  • Zhejiang Hisun Pharmaceutical Co Ltd
  • Zhejiang Huahai Pharmaceutical Co Ltd
  • ZZ Biotech LLC
Note: Product cover images may vary from those shown
Adroll
adroll